Symposium (VI)
First line combination therapy or sequential therapy for HCC
September 25, 2021（Saturday）13:40-15:20
Conference Room D
Conference Room D
* you can left or right swipe program.
| Time | Topic | Speaker | Moderator |
|---|---|---|---|
| Opening Remarks |
Shi-Ming Lin
Linkou Chang Gung Memorial Hospital
|
||
| Landscape of systemic therapy: 2021 and 2022 |
Ann-Lii Cheng
National Taiwan University Hospital
|
Shi-Ming Lin
Linkou Chang Gung Memorial Hospital
|
|
| Combination therapy in Japan: first line setting |
Masatoshi Kudo
Kindai University, Japan
Shi-Ming Lin
Linkou Chang Gung Memorial Hospital
|
||
| Sequential therapy: TKI or anti-VEGF monoclonal antibody |
Chia-Jui Yen
National Cheng Kung University Hospital
|
Kuan-Yang Chen
Taipei City Hospital Renai Branch
|
|
| Role of locoregional therapy in the era of systemic therapy |
Chen-Chun Lin
Linkou Chang Gung Memorial Hospital
Kuan-Yang Chen
Taipei City Hospital Renai Branch
|
||
| Panel Discussion |
All Speakers
|
All Moderators
|
|
| Closing Remarks |
Shi-Ming Lin
Linkou Chang Gung Memorial Hospital
|
||
* you can left or right swipe program.